Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $961.04M.
ENTERPRISE VALUE (EV)
$961.04M
Geron Corporation
Market Cap
$790.35M
Enterprise Value (EV)
$961.04M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Geron Corporation (GERN) | $790.35M | $961.04M |
| AdaptHealth Corp. (AHCO)vs › | $795.19M | $2.82B |
| Gyre Therapeutics, Inc. (GYRE)vs › | $797.70M | $757.83M |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $787.12M | $805.47M |
| InMode Ltd. (INMD)vs › | $805.59M | $413.87M |
| Apnimed, Inc. (APMD)vs › | $806.22M | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $776.21M | $747.71M |
| Design Therapeutics, Inc. (DSGN)vs › | $770.72M | $759.84M |
| Mesa Laboratories, Inc. (MLAB)vs › | $770.55M | $841.21M |
| Ardelyx, Inc. (ARDX)vs › | $823.55M | $982.54M |
Market Cap
$790.35M
Total Debt
$250.13M
Cash
$79.44M
Enterprise Value
$961.04M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
